Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07FLB
|
||||
| Former ID |
DNC005909
|
||||
| Drug Name |
N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H23N3O3
|
||||
| Canonical SMILES |
CCCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C
|
||||
| InChI |
1S/C13H23N3O3/c1-5-6-7-10(11(17)15-9-8-14)16-12(18)19-13(2,3)4/h10H,5-7,9H2,1-4H3,(H,15,17)(H,16,18)/t10-/m0/s1
|
||||
| InChIKey |
KXUSXCUMFSXFIW-JTQLQIEISA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [527885] | |
| Cathepsin S | Target Info | Inhibitor | [527885] | ||
| Cathepsin K | Target Info | Inhibitor | [527885] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.